Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07524972) titled 'Antenatal Magnesium Sulphate in High-Risk Preterm Patients' on April 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Cairo University
Condition:
Cerebral Palsy
Magnesium Sulfate Overdose
Intervention:
Drug: Magnesium sulfate
Recruitment Status: Recruiting
Phase: Phase 3
Date of First Enrollment: May 1, 2026
Target Sample Size: 138
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/study/...